Final Program

286 TUESDAY • MAY 17
P632
P633
P634
P635
Facilitator:
P636
P637
P638
P639
P640
P641
Facilitator:
P642
P643
P644
P645
Differences in Perceptual Experiences of Breathlessness and
Impairment Between People with Moderate-Severe COPD in
Australia and the United Kingdom/A.-M. Russell, K.N. Johnston,
J. Yorke, M.T. Williams, London, United Kingdom, p.A5540
Impact of a Structured Therapeutic Education Program for
COPD Patients on Preventing Readmissions (APRENDEEPOC
Program)/C. Hernandez, N. Seijas, A. Folch, C. Grane, I. Orts, C.
Esquinas, J. Aibar, L. Macia, Barcelona, Spain, p.A5541
Functional Assessment of Patients with COPD, Pulmonary
Hypertension and Interstitial Lung Diseases Using the Index
Oxygen Desaturation-Distance Ratio (DDR)/F. Burgos, X. Alsina,
C. Gistau, I. Blanco, J. Roca, Barcelona, Spain, p.A5542
Exercise and Pulmonary Rehabilitation Participation Among
Patients with Alpha-1 Antitrypsin Deficiency/J. Nolte, T. Kurtz,
M.L. Brantly, Gainesville, FL, p.A5543
R.T. Disler, PhD, RN, Sydney, Australia
Correlates of Sleep Quality in Women: Results of the National
Sleep Foundation 2013 Poll/E.R. Chasens, L.M. Baniak, C.E.
Kline, Pittsburgh, PA, p.A5544
Review of Nurse Supported Sodium Oxybate Service for
Patients with Narcolepsy/M.F. Docherty, C. Carlin, C. Livingston,
E. Livingston, Glasgow, United Kingdom, p.A5545
Sleep and Activity as Predictors of Subjective Health Status in
Middle-Aged Women/L.M. Baniak, C.E. Kline, J.L. Morris, E.R.
Chasens, Pittsburgh, PA, p.A5546
Assisting Tobacco Users to Quit with Text Messaging/P.A.
Folan, C. Fardellone, A. Spatarella, N. Kohn, A. Talwar, Great
Neck, NY, p.A5547
Nurse-Conducted Smoking Cessation Program in Patients
Admitted in a Respiratory Ward Hospitalization/D. Macias, C.
Florencio, J. Hilares, V. Gomez, N. Reyes, I. Alfageme, Seville,
Spain, p.A5548
Patients’ Views About Living and Dying with Pulmonary
Arterial Hypertension/I. Armstrong, J. Yorke, J. Warden, P.
Sephton, L. McGowan, Sheffield, United Kingdom, p.A5549
Z. Chen, BSN, Seattle, WA
The Lived Experience of Idiopathic Pulmonary Fibrosis: A
Qualitative Study/I. Egerod, D. Overgaard, G. Kaldan, K. Marsaa,
T.L. Nielsen, S.B. Shaker, Copenhagen, Denmark, p.A5550
HIV Infection and Comorbidity as Predictors of Palliative Care
Consultation in Adults Hospitalized with Heart Failure/S.L.
Feder, S. Jeon, J.P. Tate, J. Womack, M. Funk, N. Redeker, K.
Akgun, West Haven, CT, p.A5551
Patterns of Healthcare Utilization by Patients with Interstitial
Lung Disease/A. Rodriguez, A. Nastase, K.S. Knox, G. Carr,
Tucson, AZ, p.A5552
Having to Get to the End of the Rope to Realize the Existence
of Chronic Obstructive Pulmonary Disease- Patients’ and
Families’ Experiences/H. Jonsdottir, G.H. Bragadottir, B.S.
Halldorsdottir, T.S. Ingadottir, Reykjavik, Iceland, p.A5553
P646
P647
C60
The Relaxation Effects of Hand-Massage Therapy on
Autonomic Nervous Function and Emotions among Patients
Receiving Palliative Care/T. Sato, Y. Yamasaki, R. Maruyama,
Sendai, Japan, p.A5554
Pecs that will Leave You Breathless/K.J. Jackson, San
Francisco, CA, p.A5555
THEMATIC POSTER SESSION
ALL ABOUT CYSTIC FIBROSIS
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area E, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P513
P514
P515
P516
P517
P518
Facilitator:
P519
P520
F.A. Ratjen, MD, PhD, Toronto, Canada
The ATP Binding Cassette C4 (ABCC4) Transporter Regulates
Extracellular cAMP Transport, Intracellular PKA Activity, and
CFTR Channel Activity in Human Airway Epithelial Cells/
C.F. Rider, R. Newton, C. Bear, C. Carlsten, J.A. Hirota,
Vancouver, Canada, p.A5557
Characterization of an Inhaled Epithelial Sodium Channel
(ENaC) Blocker in Mice to Improve Mucociliary Clearance/J.E.
Phillips, B. Bennett, D. Fong, M. Fiorino, X. Zhang, K. Edson, J.A.
Johnston, Thousand Oaks, CA, p.A5564
Nano-Based Autophagy-Induction Rescues DF508-CFTR and
Pa Infection in CF Cells/S.M. Brockman, M. Bodas, P.
Chandramani, N. Vij, Mount Pleasant, MI, p.A5570
Bioengineering of Optimal AAV Based Vectors for Effective
Gene Therapy for Bronchial Epithelium/Y.M. Colon-Cortes, E.
Martin, M. Abu- Hasan, A. Srivastava, G. Aslanidi, Gainesville, FL,
p.A5571
Airway Therapeutic Discovery Using a Porcine Model of Cystic
Fibrosis/D. Cook, M. Stroik, R.J. Adam, B. Deonovic, L. Reznikov,
N. Gansemer, K.F. Au, D. Meyerholz, D. Stoltz, Iowa City, IA,
p.A5572
Losartan Rescues Cystic Fibrosis (CF)-Related Mucociliary
Dysfunction in CF Cells In Vitro and in a Novel CF Sheep
Model In Vivo/M. Salathe, N. Baumlin, A. Kis, S. Krick, A. Schmid,
J.R. Sabater, W.M. Abraham, Miami, FL, p.A5573
J. Chmiel, MD, MPH, Cleveland, OH
The Gene Expression Profile of Signal Transducer and
Activator of Transcription (STATs) and Suppressor of Cytokine
Signaling (SOCS) in Cystic Fibrosis/S. Sagwal, M. Singh, R.
Prasad, Chandigarh, India, p.A5556
Spdef-Independent Mucin Production During
Non-Th2-Dominated Pulmonary Inflammation Revealed in the
Scnn1b-Tg Muco-Obstructive Mouse Model/G. Chen, A. Volmer,
K. Wilkinson, K. Terrell, W.K. O’Neal, A. Livraghi-Butrico, R.C.
Boucher, Chapel Hill, NC, p.A5558
ATS 2016 • San Francisco